In glioma, amplification of epidermal growth factor receptor (EGFR) and/or its constitutively active mutant form, EGFRvIII, promotes the expression of TF, PARs, and ectopic synthesis of FVII, thus sensitizing the cells to TF-mediated signaling [106]. This evidence concerns the gene EGFR and central nervous system cancer.